NovelStem International Corp. (NSTM)
USD 0.01
(23.46%)
USD 0.01
(23.46%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 3.32 Million USD | 1052.57% |
| 2022 | 288.45 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2013 | 26.77 Thousand USD | 1143.96% |
| 2012 | 2152.00 USD | -86.72% |
| 2011 | 16.2 Thousand USD | -57.6% |
| 2010 | 38.21 Thousand USD | -51.17% |
| 2009 | 78.26 Thousand USD | -67.41% |
| 2008 | 240.15 Thousand USD | -31.43% |
| 2007 | 350.26 Thousand USD | 704.42% |
| 2006 | 43.54 Thousand USD | -99.21% |
| 2005 | 5.47 Million USD | 520.11% |
| 2004 | 883.67 Thousand USD | -78.99% |
| 2003 | 4.2 Million USD | 1663.36% |
| 2002 | 238.54 Thousand USD | -47.96% |
| 2001 | 458.39 Thousand USD | -36.47% |
| 2000 | 721.52 Thousand USD | -27.85% |
| 1999 | 1 Million USD | -41.18% |
| 1998 | 1.7 Million USD | -26.09% |
| 1997 | 2.3 Million USD | 228.57% |
| 1996 | 700 Thousand USD | 250.0% |
| 1995 | 200 Thousand USD | 100.0% |
| 1994 | 100 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 823.11 Thousand USD | 1.55% |
| 2024 Q1 | 810.52 Thousand USD | -75.62% |
| 2023 Q1 | - USD | -100.0% |
| 2023 FY | 3.32 Million USD | 1052.57% |
| 2023 Q4 | 3.32 Million USD | 132.49% |
| 2023 Q3 | 1.43 Million USD | -18.8% |
| 2023 Q2 | 1.76 Million USD | 0.0% |
| 2022 Q3 | 168.2 Thousand USD | 68.21% |
| 2022 Q4 | 288.45 Thousand USD | 71.48% |
| 2022 FY | 288.45 Thousand USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q2 | 100 Thousand USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2013 Q3 | 28.64 Thousand USD | -5.93% |
| 2013 FY | 26.77 Thousand USD | 1143.96% |
| 2013 Q1 | 32.29 Thousand USD | 1400.7% |
| 2013 Q2 | 30.44 Thousand USD | -5.73% |
| 2013 Q4 | 26.77 Thousand USD | -6.53% |
| 2012 Q2 | 10.38 Thousand USD | -27.32% |
| 2012 Q3 | 6341.00 USD | -38.91% |
| 2012 Q4 | 2152.00 USD | -66.06% |
| 2012 FY | 2152.00 USD | -86.72% |
| 2012 Q1 | 14.28 Thousand USD | -11.86% |
| 2011 Q3 | 21.39 Thousand USD | -19.07% |
| 2011 FY | 16.2 Thousand USD | -57.6% |
| 2011 Q1 | 33.15 Thousand USD | -13.25% |
| 2011 Q4 | 16.2 Thousand USD | -24.28% |
| 2011 Q2 | 26.44 Thousand USD | -20.25% |
| 2010 Q2 | 37.44 Thousand USD | -35.22% |
| 2010 Q4 | 38.21 Thousand USD | 105.14% |
| 2010 Q3 | 18.63 Thousand USD | -50.24% |
| 2010 Q1 | 57.79 Thousand USD | -26.15% |
| 2010 FY | 38.21 Thousand USD | -51.17% |
| 2009 Q4 | 78.26 Thousand USD | -22.54% |
| 2009 Q1 | 184.27 Thousand USD | -23.27% |
| 2009 FY | 78.26 Thousand USD | -67.41% |
| 2009 Q2 | 135.4 Thousand USD | -26.52% |
| 2009 Q3 | 101.03 Thousand USD | -25.38% |
| 2008 Q1 | 313.01 Thousand USD | -10.63% |
| 2008 FY | 240.15 Thousand USD | -31.43% |
| 2008 Q3 | 217.88 Thousand USD | -28.17% |
| 2008 Q2 | 303.35 Thousand USD | -3.09% |
| 2008 Q4 | 240.15 Thousand USD | 10.22% |
| 2007 Q1 | 74.37 Thousand USD | 70.81% |
| 2007 FY | 350.26 Thousand USD | 704.42% |
| 2007 Q4 | 350.26 Thousand USD | 10.52% |
| 2007 Q3 | 316.93 Thousand USD | 175.62% |
| 2007 Q2 | 114.99 Thousand USD | 54.61% |
| 2006 Q2 | 47.5 Thousand USD | -99.14% |
| 2006 Q4 | 43.54 Thousand USD | 11.94% |
| 2006 FY | 43.54 Thousand USD | -99.21% |
| 2006 Q3 | 38.89 Thousand USD | -18.13% |
| 2006 Q1 | 5.51 Million USD | 0.69% |
| 2005 Q4 | 5.47 Million USD | 6683.29% |
| 2005 Q3 | 80.78 Thousand USD | -19.28% |
| 2005 Q2 | 100.08 Thousand USD | -89.42% |
| 2005 Q1 | 945.53 Thousand USD | 7.0% |
| 2005 FY | 5.47 Million USD | 520.11% |
| 2004 Q4 | 883.67 Thousand USD | -2.97% |
| 2004 FY | 883.67 Thousand USD | -78.99% |
| 2004 Q1 | 4.17 Million USD | -0.76% |
| 2004 Q2 | 142.47 Thousand USD | -96.59% |
| 2004 Q3 | 910.75 Thousand USD | 539.22% |
| 2003 Q2 | 3.74 Million USD | 4.08% |
| 2003 Q1 | 3.6 Million USD | 1409.81% |
| 2003 FY | 4.2 Million USD | 1663.36% |
| 2003 Q3 | 3.91 Million USD | 4.47% |
| 2003 Q4 | 4.2 Million USD | 7.41% |
| 2002 FY | 238.54 Thousand USD | -47.96% |
| 2002 Q3 | 311.47 Thousand USD | -90.25% |
| 2002 Q4 | 238.54 Thousand USD | -23.42% |
| 2002 Q2 | 3.19 Million USD | 795.72% |
| 2002 Q1 | 356.54 Thousand USD | -22.22% |
| 2001 Q1 | 667.21 Thousand USD | -7.53% |
| 2001 FY | 458.39 Thousand USD | -36.47% |
| 2001 Q2 | 346.93 Thousand USD | -48.0% |
| 2001 Q4 | 458.39 Thousand USD | 75.68% |
| 2001 Q3 | 260.93 Thousand USD | -24.79% |
| 2000 Q3 | 853.53 Thousand USD | 10.16% |
| 2000 Q4 | 721.52 Thousand USD | -15.47% |
| 2000 Q2 | 774.81 Thousand USD | -11.22% |
| 2000 Q1 | 872.77 Thousand USD | -12.72% |
| 2000 FY | 721.52 Thousand USD | -27.85% |
| 1999 Q4 | 1 Million USD | -23.08% |
| 1999 Q3 | 1.3 Million USD | -7.14% |
| 1999 FY | 1 Million USD | -41.18% |
| 1999 Q1 | 1.6 Million USD | -5.88% |
| 1999 Q2 | 1.4 Million USD | -12.5% |
| 1998 Q2 | 2.3 Million USD | 15.0% |
| 1998 Q3 | 1.7 Million USD | -26.09% |
| 1998 Q4 | 1.7 Million USD | 0.0% |
| 1998 Q1 | 2 Million USD | -13.04% |
| 1998 FY | 1.7 Million USD | -26.09% |
| 1997 Q3 | 1.1 Million USD | 120.0% |
| 1997 FY | 2.3 Million USD | 228.57% |
| 1997 Q4 | 2.3 Million USD | 109.09% |
| 1997 Q1 | 600 Thousand USD | -14.29% |
| 1997 Q2 | 500 Thousand USD | -16.67% |
| 1996 Q4 | 700 Thousand USD | 16.67% |
| 1996 FY | 700 Thousand USD | 250.0% |
| 1996 Q1 | 1 Million USD | 400.0% |
| 1996 Q2 | 700 Thousand USD | -30.0% |
| 1996 Q3 | 600 Thousand USD | -14.29% |
| 1995 FY | 200 Thousand USD | 100.0% |
| 1995 Q3 | 100 Thousand USD | 0.0% |
| 1995 Q4 | 200 Thousand USD | 100.0% |
| 1994 Q4 | 100 Thousand USD | 0.0% |
| 1994 FY | 100 Thousand USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | 100 Thousand USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 6000.00 USD | -55309.983% |
| Arrayit Corporation | - USD | -Infinity% |
| Atlantic International Corp. | 1.29 Million USD | -156.228% |
| Biocept, Inc. | 10.37 Million USD | 67.956% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 51.3 Million USD | 93.52% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 61.22 Million USD | 94.57% |
| HTG Molecular Diagnostics, Inc. | 546.32 Thousand USD | -508.54% |
| iMD Companies, Inc. | 1.1 Million USD | -201.232% |
| IDenta Corp. | 428.17 Thousand USD | -676.456% |
| Interpace Biosciences, Inc. | 4.24 Million USD | 21.645% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | - USD | -Infinity% |
| Lumos Diagnostics Holdings Limited | - USD | -Infinity% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 278 Thousand USD | -1095.899% |
| Optigenex Inc. | 4.42 Million USD | 24.903% |
| PharmChem, Inc. | - USD | -Infinity% |
| Proteome Sciences plc | 1.63 Million USD | -103.838% |
| Response Genetics, Inc | 4.91 Million USD | 32.399% |
| Rennova Health, Inc. | 359.19 Thousand USD | -825.575% |
| RushNet, Inc. | 4.25 Million USD | 21.818% |
| ScreenPro Security Inc. | 249.05 Thousand USD | -1234.912% |
| Stella Diagnostics Inc. | 798.44 Thousand USD | -316.386% |
| StageZero Life Sciences Ltd. | 576.38 Thousand USD | -476.805% |
| Todos Medical Ltd. | 33 Million USD | 89.926% |